合計 50 件の最近のインサイダー取引記録が記録されています Alumis Inc. Common Stock (ALMS), 内訳は 46 件の買い および 3 件の売り. インサイダー買い総額は $94.64M インサイダー売り総額は RSU アワード.
最近活動のある主要インサイダーには Tananbaum James B., Foresite Capital Management Vi Llc, Foresite Labs, Llc. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ALMS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
その他（売り） |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
その他（売り） |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
その他（売り） |
1,123,337 |
- |
- |
- |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
RSU 付与（制限付株式） |
745,875 |
$26.31 |
$19.62M |
745,875 |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU 付与（制限付株式） |
190,875 |
$26.31 |
$5.02M |
190,875 |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
RSU 付与（制限付株式） |
202,225 |
$26.31 |
$5.32M |
202,225 |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
RSU 付与（制限付株式） |
216,675 |
$26.31 |
$5.7M |
216,675 |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
RSU 付与（制限付株式） |
221,450 |
$26.31 |
$5.83M |
221,450 |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
RSU 付与（制限付株式） |
190,225 |
$26.31 |
$5M |
190,225 |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
RSU 付与（制限付株式） |
186,200 |
$26.31 |
$4.9M |
186,200 |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
588,235 |
$17.00 |
$10M |
1,853,488 |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
情報に基づく買い |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
情報に基づく買い |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
情報に基づく買い |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
不明 |
- |
- |
- |
8,994 |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
64,969 |
$8.95 |
$581.47K |
1,143,845 |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
66,027 |
$8.18 |
$540.1K |
1,078,876 |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
100,000 |
$7.75 |
$775K |
1,012,849 |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
96,000 |
$7.55 |
$724.8K |
912,849 |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
86,350 |
$7.46 |
$644.17K |
816,849 |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
38,702 |
$7.64 |
$295.68K |
730,499 |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
48,537 |
$7.64 |
$370.82K |
691,797 |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
情報に基づく買い |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
情報に基づく買い |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
情報に基づく買い |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-20 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
125,743 |
$7.20 |
$905.35K |
643,260 |
| 2025-11-19 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
137,772 |
$6.56 |
$903.78K |
517,517 |
| 2025-11-19 |
Tananbaum James B. |
10 Percent Owner |
情報に基づく買い |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
情報に基づく買い |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Labs, Llc |
10 Percent Owner |
情報に基づく買い |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-18 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
102,652 |
$6.05 |
$621.04K |
379,745 |
| 2025-11-18 |
Tananbaum James B. |
10 Percent Owner |
情報に基づく買い |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
情報に基づく買い |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Labs, Llc |
10 Percent Owner |
情報に基づく買い |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-17 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
914 |
$5.51 |
$5.04K |
277,093 |
| 2025-11-17 |
Tananbaum James B. |
10 Percent Owner |
情報に基づく買い |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
情報に基づく買い |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Labs, Llc |
10 Percent Owner |
情報に基づく買い |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-13 |
Akkaraju Srinivas |
Director |
情報に基づく買い |
276,179 |
$5.25 |
$1.45M |
276,179 |
| 2025-07-30 |
Akkaraju Srinivas |
Director |
RSU 付与（制限付株式） |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Machado Patrick |
Director |
RSU 付与（制限付株式） |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Yao Zhengbin |
Director |
RSU 付与（制限付株式） |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Srivastava Sapna |
Director |
RSU 付与（制限付株式） |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Tetrault Lynn A. |
Director |
RSU 付与（制限付株式） |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-29 |
Babler Martin |
President, CEO and Chairman |
RSU 付与（制限付株式） |
150,000 |
$3.95 |
$592.5K |
150,000 |
| 2025-07-29 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
RSU 付与（制限付株式） |
111,950 |
$3.95 |
$442.2K |
111,950 |
| 2025-07-29 |
Schroer John R. |
Chief Financial Officer |
RSU 付与（制限付株式） |
28,000 |
- |
- |
28,000 |
| 2025-07-29 |
Goldstein David M |
Chief Scientific Officer |
RSU 付与（制限付株式） |
27,000 |
- |
- |
29,115 |
| 2025-07-29 |
Drappa Jorn |
Chief Medical Officer |
RSU 付与（制限付株式） |
25,450 |
- |
- |
28,450 |
| 2025-07-29 |
Richardson Derrick |
SVP, People and Culture |
RSU 付与（制限付株式） |
42,800 |
- |
- |
42,800 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
